Listed

Nutex Health Inc.: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Apr 17, 2018 and accepted by EDGAR at Apr 17, 2018, 12:18 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2017-01-01 to 2017-12-31$30.5kus-gaap:CostOfRevenue
Gross profit12 months2017-01-01 to 2017-12-31−$7.3kus-gaap:GrossProfit
Operating income12 months2017-01-01 to 2017-12-31−$5.7mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$367.4kus-gaap:InterestExpense
Net income12 months2017-01-01 to 2017-12-31$582.1kus-gaap:NetIncomeLoss
Diluted EPS12 months2017-01-01 to 2017-12-31$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2017-01-01 to 2017-12-31−$714.6kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2017-12-31$9.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$55.1kus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$3.3mus-gaap:Assets
Current liabilitiesAt period end2017-12-31$959.8kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2017-12-31$2.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001607062-18-000127. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.